Efficacy of Ultrasound-assisted Caudal Epidural Pulsed Radiofrequency for Anal and Perineal Pain in Cancer Patients, a Prospective Randomized Clinical Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Perineal Pain
- Sponsor
- Assiut University
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- visual analog scale (VAS) score 4 weeks post-intervention
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
Our primary goal will be to investigate the analgesic efficacy of ultrasound (US)-assisted caudal epidural PRF (pulsed radiofrequency)( stimulation in patients with perineal or anal pain cancer patients using (visual analog scale (VAS) scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks; secondary outcomes will be the effects on opioid use and total opioid use in the 24 h, quality of life, patient satisfaction and opioid and intervention related side effects.
Investigators
Fatma Adel El sherif,MD
associate professor of anesthesia, intensive care and pain management
Assiut University
Eligibility Criteria
Inclusion Criteria
- •American Society of Anesthesiology physical status of I or III (ASA), of both sex
- •cancer-related anal or perineal pain
Exclusion Criteria
- •coagulopathies
- •allergies to the contrast dye
- •patients with moderate or significant cardiac/respiratory disease or hepatic
Outcomes
Primary Outcomes
visual analog scale (VAS) score 4 weeks post-intervention
Time Frame: 8 weeks
Our primary goal will be to investigate the analgesic efficacy of ultrasound-assisted caudal epidural PRF stimulation in patients with perineal or anal pain cancer patients using VAS scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks